| Date | Title | Description |
| 19.01.2022 | Article in Bio Market Insights: “Forget the hype. Invest in technology that makes sense” | Rob van der Meij, Partner at Capricorn Partners sat down with Kathryn Sheridan from Sustainability Consult to share his insider perspective from the world of biotech financing. |
| 13.01.2022 | Solvay to collaborate with Trillium on bio-based acrylonitrile for carbon fiber applications | Brussels, Belgium : 12 January 2022 – Solvay and Trillium Renewable Chemicals have signed a letter of intent to develop the supply chain for bio-based acrylonitrile (bio-ACN). Trillium will supply Solvay with bio-ACN from Trillium’s planned... |
| 05.01.2022 | DMC Appoints Ashley Jenkins as CFO | Boulder CA, USA: 5 January 2022 – DMC Biotechnologies has appointed Ashley Jenkins as Chief Financial Officer (CFO). Ashley joins DMC from Felix Energy where she has worked since 2013. Ashley joins DMC’s Boulder, Colorado office. |
| 21.12.2021 | Article on Circular Bioeconomy in “Platform Life Sciences” of November 2021 | The slight difference : |
| 02.12.2021 | Capricorn Further Invests in DMC Series B | Leuven, Belgium: 2 December 2021 – DMC Biotechnologies has completed the first close of its Series B fundraising, raising $34 million (USD) with investment from Cibus Enterprise, Capricorn Partners, Sofinnova Partners, Breakthrough Energy V... |
| 22.10.2021 | Capricorn Partners leads investment round in Belgian digital health tech company DEO | Leuven, Belgium: 22 October 2021 – DEO, a company that provides hospitals and healthcare industry partners with comprehensive data insights inside the operating room (OR), has announced a € 3.65 million funding round. Capricorn Partners led... |
| 21.10.2021 | FEops appoints Digital Health expert Euan Thomson to its Board of Directors | Ghent, Belgium: 21 October 2021 – FEops, a cloud-based digital health player in the structural heart space, is glad to announce the nomination of Euan Thomson as a board member to its Board of Directors. |
| 14.10.2021 | FEops HEARTguide authorized by FDA for unprecedented LAAo planning capabilities | Ghent, Belgium: 14 October 2021 – FEops today announced that it received De Novo authorization from the U.S. Food and Drug Administration (FDA) for FEops HEARTguide™ pre-operative planning of left atrial appendage occlusion with the Boston ... |
| 07.10.2021 | Aconterra forms Strategic Partnership with Capricorn and invests € 10 million in Capricorn Digital Growth Fund | Strategic partnership to collaborate on smart building technology investments |
| 24.09.2021 | “Dit wordt het decennium van de neurowetenschap” | De Tijd: 24 september 2021 – Het Leuvense Capricorn zoekt nog investeerders voor zijn Digital Growth Fund. Beheerder Steven Lambert, die jaren in Silicon Valley werkte, ziet in onze regio genoeg troeven om groots te denken. |
| 09.09.2021 | Capricorn Partners and FPIM-SFPI lead financing round at Qpinch | Leuven, Belgium: September 1, 2021 — Qpinch, a Belgian scale-up that supplies industrial heat pumps to the chemical, petrochemical and food industry has attracted € 10 million of growth equity from FPIM-SFPI and Capricorn Partners. Qpinch s... |
| 27.08.2021 | Black Bear & HELM sign Memorandum of Understanding to bring sustainable Carbon Black to the market by 2023 | Black Bear Carbon B.V. (“Black Bear ”) and HELM AG (“HELM”) have announced today a long-term supply chain and marketing cooperation. Black Bear will produce recovered Carbon Black from used tires via its proprietary technology. Both compani... |
| 03.08.2021 | Spectricity raises € 14 million series B funding as it accelerates plans to deliver industry leading hyperspectral sensing to mobile and consumer devices | Mechelen, Belgium: 3 August 2021 – Spectricity, a leading provider of hyperspectral sensing solutions for mobile and consumer devices, announced today a € 14 million (US$ 16 million) Series B funding round to further accelerate the developm... |
| 15.07.2021 | iSTAR Medical receives US FDA approval to start pivotal trial for MINIject in glaucoma patients | Wavre, Belgium: 15 July 2021 – iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery (MIGS), announced today that the U.S. Food and Drug Administration (FDA) granted it Investigational Device Exemptio... |
| 30.06.2021 | Game-changing catalytic dewaxing: Zeopore reaches 30°C cloud point improvement while keeping diesel yield loss under 2wt%, confirmed in a high throughput testing campaign at hte GmbH | Leuven, Belgium: 30 June 2021 – Making diesel winter-proof is currently an expensive process as refiners face high diesel yield losses or have to turn to expensive additives or kerosene blending. hte GmbH examined the catalytic dewaxing per... |
| 16.06.2021 | NGDATA Joins Growing Ecosystem of Partners Supporting the IBM Cloud for Financial Services | NEW YORK CITY, NEW YORK – June 16, 2021 – NGDATA, a customer data platform that drives one-to-one customer engagement, today announced it has joined IBM’s (NYSE: IBM) growing ecosystem of more than 100 Global Systems Integrators (GSIs), Ind... |
| 25.05.2021 | Nexstim extends agreement with Canadian distributor and receives order for three NBT® systems | Helsinki, Finland: 25 May 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that it has extended its agreement with Canadian Health Solutions group, the Company’s distributor in Canada, for an additional five years. |
| 25.05.2021 | Capricorn Fusion China Fund announces intermediate closing bringing commitments to over € 30 million | Leuven, Belgium: 30 April 2021 – Capricorn Partners, the Leuven-based independent manager of venture capital and equity funds, announces the intermediate closing of its Capricorn Fusion China Fund (“CFCF”) securing more than € 30 million of... |
| 18.05.2021 | Nexstim granted authorization for commercial distribution of NBS system in Australia | Helsinki, Finland: 18 May 2021- Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces having received authorization for distribution of its NBS system by the Australian Therapeutic Goods Administration (TGA). |
| 17.05.2021 | Impressive new study results suggest potential new therapeutic use for Nexstim SmartFocus® nTMS in postsurgical rehabilitation of Paresis | Helsinki, Finland: 17 May 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that a new study published in Brain Stimulation in May reports that the therapeutic use of Nexstim navigated repetitive transcranial magnetic stimulation (nrTMS) ... |
| 17.05.2021 | Black Bear Carbon raises € 7.5 million in a first closing for its new flagship plant | Nederweert, Netherlands: 17 May 2021 – BBC was confronted with a fire that destroyed its first demo-plant in February 2019 and as a result, the company faced operational and financial challenges. Nevertheless, Black Bear Carbon has shown re... |
| 13.05.2021 | DMC’s Downstream Processing Proven At Scale | Boulder, CO, USA: 13 May 2021 – DMC Biotechnologies has completed downstream processing for its first product, the amino acid L-alanine. The downstream processing was done at EW Biotech in Leuna, Germany following the successful demonstrati... |
| 12.05.2021 | Indigo Diabetes appoints Paul Moraviec as Chairman of the Board | Ghent, Belgium: 12 May 2021 – Indigo Diabetes NV, a pioneering developer of medical solutions using nanophotonics, is pleased to announce the appointment of Paul Moraviec as Chairman of its Board of Directors. |
| 07.05.2021 | Nexstim receives a new NBS system order from a leading California based academic hospital | Helsinki, Finland : 7 May 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that it has received an NBS system order from a distinguished academic hospital based in Northern California, US. |
| 27.04.2021 | Prolupin announces Paul Denayer as new CEO | Grimmen, Germany: 27 April 2021 – The European market leader in plant-based lupine protein food and beverages is pleased to announce the appointment of Paul Denayer to the position of CEO. Paul brings with him more than 20 years of relevant... |
| 22.04.2021 | DMC and Conagen partner for commercial manufacturing of L-alanine | Boulder, CO, USA: 21 April 2021 – DMC Biotechnologies and Conagen Inc. have entered into a manufacturing agreement for the commercial production of DMC’s first product, L-alanine. |
| 20.04.2021 | Capricorn Partners and Southern Research Create Trillium Renewable Chemicals | Birmingham, AL, USA and Leuven, Belgium: April 20, 2021 – Capricorn Partners and Southern Research have jointly created a new Alabama-based start-up company Trillium Renewable Chemicals. Southern Research has exclusively licensed its patent... |
| 16.04.2021 | Nexstim receives positive feedback from Mind Matters Psychiatry MD on use of their two NBT® systems to treat MDD | Helsinki, Finland: 16 april 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that the company’s SmartFocus® nTMS technology used at Mind Matters Psychiatry MD, US has generated positive feedback from its use in treating patients with dep... |
| 08.04.2021 | Capricorn Partners leads the series B capital increase at REIN4CED | Leuven, Belgium: 8 April 2021 — REIN4CED NV, a Belgian manufacturer of advanced composite bicycle frames has successfully completed its series B capital increase of € 7.0 million led by Capricorn Partners. The investment was carried by the ... |
| 30.03.2021 | Confo Therapeutics awarded € 1 million VLAIO grant for pre-clinical development of CFTX-1554, an AT2R modulator for the treatment of neuropathic pain | Ghent, Belgium: 30 March 2021 – Confo Therapeutics announced today that it has been awarded a € 1 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The grant will support the pre-clinical development of CFTX-1554, Confo... |
| 24.03.2021 | DMC CTO & Co-Founder Mike Lynch publishes Technoeconomic Analysis (TEA) Calculator to take the guesswork out of bioprocess development | Boulder, CO, USA: 24 March 2021 – DMC CTO and Co-Founder Mike Lynch has launched a web-based calculator to assess the economic feasibility of products made from fermentation. The Bioprocess Technoeconomic Analysis (TEA) tool will help users... |
| 18.03.2021 | Indigo Diabetes initiates first clinical study of its continuous glucose monitoring sensor | Ground-breaking subcutaneous sensor aims to continuously monitor multiple metabolites including ketones in people living with diabetes |
| 15.03.2021 | DMC demonstrates full commercial scale at record speed | Boulder, CO, USA: 15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. |
| 12.03.2021 | Nexstim gives an update on its promising treatment results of Major Depressive Disorder | Helsinki, Finland: 12 March 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) reports very promising clinical outcomes of the 159 patients who have completed Nexstim SmartFocus® rTMS treatment with Nexstim NBT® system for major depressive disorder ... |
| 08.03.2021 | Mainstay Medical announces commercial launch of ReActiv8® in Australia | Dublin, Ireland: 8 March 2021 – Mainstay Medical Holdings plc today announced the commercial launch in Australia of ReActiv8®, its implantable neurostimulation system to treat chronic low back pain. |
| 05.03.2021 | BNP Paribas Fortis Private Equity, Capricorn Fusion China Fund et al. invest in solid state lidar company, XenomatiX | Leuven, Belgium: 5 March 2021 – XenomatiX, provider of true solid state lidars for ADAS, autonomous driving and road digitization, has received funds from 9 different entities including two international investment funds, BNP Paribas Fortis... |
| 01.03.2021 | Hologic acquires European Molecular diagnostic company Diagenode for approximately $159 million | Marlborough, Mass., USA: 1 March 2021 – Hologic, Inc (Nasdaq: HOLX), a global leader in women’s health, announced today that it has acquired Diagenode, a privately held, European developer and manufacturer of molecular diagnostic assays and... |
| 16.02.2021 | Mainstay Medical announces US$ 108 million equity financing transaction | Funding to support U.S. commercial launch and global expansion |
| 28.01.2021 | German University Hospital orders Nexstim NBS system with NexSpeech | Helsinki, Finland: 28 January 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that a University Hospital in Germany has ordered a Nexstim NBS System with NexSpeech. |
| 25.01.2021 | Mainstay Medical announces key strategic Vice President hires to drive global commercial expansion | Appointments to support upcoming commercial launch of ReActiv8 in the US and foster further growth in Europe and Australia |
| 13.01.2021 | New study presents impressive results of Nexstim SmartFocus® nTMS Language Mapping | Helsinki, Finland: 13 January 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that a new study published in Cancers in January presents impressive results of nTMS language mapping in a large amount of patients. Using the robustness of N... |
| 22.12.2020 | Nexstim has received three new NBS System orders | Helsinki, Finland: 22 December 2020 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that it has received three new NBS system orders in December. |
| 01.12.2020 | Capricorn Digital Growth Fund invests in Dutch cybersecurity scale-up EclecticIQ | Amsterdam, the Netherlands and Leuven, Belgium: 1 December 2020 – EclecticIQ, a global threat intelligence, hunting and response technology provider, has raised € 20 million in Series‑C financing, led by Ace Management, Europe’s leading cyb... |
| 16.11.2020 | Capricorn welcomes Prof. Bart De Moor as Chairman of the Capricorn Digital Growth Fund | Bart De Moor is a full professor at the KULeuven at the Department of Electrical Engineering, and a guest professor at the University of Siena. His research interests are in numerical linear algebra, optimization, algebraic geometry, system... |
| 16.11.2020 | iSTAR Medical’s glaucoma device MINIject shows positive one-year results in European trial | Wavre, Belgium: 16 November 2020 – iSTAR Medical, a medtech company developing minimally invasive ophthalmic implants for treatment of patients with glaucoma, today announced positive one-year results from the European STAR-II clinical tria... |
| 10.11.2020 | M&A Awards Belgium: Panel of Judges nominates 15 deals – Bluebee/Illumina transaction is nominated | The M&A Awards 2020 will be presented on Thursday 18 March 2021 (if the health statusand covid-19 measures allow for it) at the magnificent Hôtel de la Poste in Brussels. For thethird year in a row, the top in M&A, corporate finance... |
| 15.10.2020 | Confo Therapeutics announces selection of first product candidate and initiation of pre-clinical development | Ghent, Belgium: 15 October 2020 – Confo Therapeutics today announced the selection of its first preclinical drug candidate, CFTX-1554, a compound designed to address peripheral neuropathic pain with the potential to address additional pain ... |
| 06.10.2020 | Industrial IoT firm Sensolus secures € 3.5 million to enhance visibility in international supply chains | Ghent, Belgium: 6 October 2020 – Sensolus, provider of IoT (Internet of Things)-based asset tracking solutions, has closed a financing round of € 3.5 million. The Belgian firm enables companies to track non-powered assets in supply chains a... |
| 05.10.2020 | Nexstim continues to report promising results in quickly growing number of patients completing SmartFocus® rTMS treatment of Major Depressive Disorder | Helsinki, Finland: 5 October 2020 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) reports very promising clinical outcomes of the 108 patients who have completed Nexstim SmartFocus® rTMS treatment with Nexstim NBT® system for major depressive disorder... |
| 01.10.2020 | Capricorn Fusion China Fund Joining forces around a shared investment belief | Leuven, Belgium: 1 October 2020 – Fusion Partners and Capricorn Partners join forces for the management of the Capricorn Fusion China Fund, aiming to deploy smart capital in 10 to 15 European and Chinese companies with ambitious transcontin... |
| 29.09.2020 | Positive outcomes for iSTAR Medical’s MIGS MINIject shown in trials of over 130 glaucoma patients | Pooled data confirm excellent safety and efficacy profile with very low rate of reintervention |
| 23.09.2020 | NGDATA solidifies its strong position in the CDP market | Ghent, Belgium: 23 September 2020 – NGDATA further solidifies its position as a more sophisticated, and intelligent, CDP. After becoming the first-ever CDP vendor to receive the RealCDP Certification by the CDP Institute, NGDATA received mo... |
| 22.09.2020 | Scaled Access Now Available on Auth0 Marketplace | Leuven, Belgium: 22 September 2020 – Scaled Access today announced the availability of its advanced access management solution on Auth0 Marketplace, a newly-launched catalog of trusted technology integrations to extend the functionality of ... |
| 04.09.2020 | BrainStim Centers orders a second Nexstim NBT® System with SmartFocus® TMS | Helsinki, Finland: 4 September 2020 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that BrainStim Centers, US has ordered a second Nexstim NBT® System with SmartFocus® TMS technology. |
| 28.08.2020 | Capricorn Partners invests in Zeopore Technologies to bring its novel zeolite catalyst technologies to market | Leuven, Belgium: 28 August 2020 – Capricorn Partners has led a successful financing round of Zeopore Technologies NV, a leading Belgian technology developer, active in the commercialization of cost-effective mesoporous zeolites for catalyti... |
| 05.08.2020 | Why we invested in Gradyent — AI for district heating | Earlier this summer, we announced our first investment out of the Capricorn Digital Growth Fund. Together with Helen Ventures and Energiiq we committed €1.9 million to Gradyent, a Netherlands based venture actively helping utility companies... |
| 27.07.2020 | Indigo Diabetes concludes a €38 million round of financing | Ghent, Belgium: 27 July 2020 – Indigo Diabetes nv, a young high-tech medical device company that develops medical solutions using nanophotonics, today announced the conclusion of a €38 million Series B funding round to further develop its p... |
| 22.06.2020 | Mainstay Medical announces US FDA approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain | Dublin, Ireland: 22 June 2020 – Mainstay Medical Holdings plc today announced that the US Food and Drug Administration (FDA) has approved the Company’s Premarket Approval (PMA) application for ReActiv8®, its implantable neurostimulation sys... |
| 18.06.2020 | Illumina announced the acquisition of Bluebee, a portfolio company of both Capricorn ICT Arkiv and Quest for Growth | Leuven, Belgium: 18 June 2020 – The announced transaction is the third successful exit of Capricorn ICT Arkiv. In 2015, Capricorn ICT Arkiv realised the successful exit of its investment in Cartagenia and in 2018 of Noona Healthcare. |
| 16.06.2020 | Capricorn Digital Growth Fund announces first investment in Dutch AI company Gradyent while also adding new investors bringing the total fund size over € 50 million | Leuven, Belgium: 16 June 2020 – Capricorn Partners announced today the intermediary closing of its Capricorn Digital Growth Fund bringing commitments to over € 50 million. At the same time the fund closed its first investment together with ... |
| 10.06.2020 | Confo Therapeutics expands Board with appointment of Rob Scott as Independent Director | Ghent, Belgium: 10 June 2020 – Confo Therapeutics today announced the addition of a new member to its Board of Directors with the appointment of Rob Scott, MD, as an Independent Director. Dr Scott’s career spans 30 years of drug discovery a... |
| 08.06.2020 | Mainstay Medical announces reimbursement approval for ReActiv8 in Australia | Dublin, Ireland: 8 June 2020 – Mainstay Medical Holdings plc today announced that ReActiv8, its implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain, has been approved for inclusion in the Prostheses List... |
| 03.06.2020 | Confo Therapeutics appoints Paolo Vicini as Chief Development Officer | New management role underscores Company’s commitment to establishing and advancing its proprietary pipeline of GPCR modulating drug candidates |
| 28.05.2020 | Seventure Partners joins ViroVet in series B funding | Animal health company focused on combatting viral infections in livestock |
| 26.05.2020 | icometrix nv appoints Dr Steve Rietiker as Chairman of the board | Leuven, Belgium and Chicago IL, USA: 26 May 2020 – icometrix, the world leader in software solutions for extracting clinically meaningful data from brain scans using artificial intelligence (AI), is proud to announce that Dr. Steve Rietiker... |
| 26.05.2020 | VOID Technologies raises £6 million in investment | Leuven, Belgium: 26 Mai 2020 – VOID Technologies Ltd. (VOID) has announced that it has raised £6 million in a funding round led by two investors: SABIC Ventures B.V., a subsidiary of SABIC, ranked as one of the world’s largest petrochemical... |
| 20.05.2020 | TruGenomix Partners with BlueBee to create the next generation Behavioral Science Data Ecosystem | Rockville, MD and San Mateo, CA USA: 20 May 2020 – The unprecedented COVID-19 crisis has unleashed global emotional trauma that is rapidly evolving into a mental health pandemic within the pandemic. While post-traumatic stress disorder (PTS... |
| 08.05.2020 | icometrix welcomes Jennifer Young as Chief Commercial Officer | Leuven, Belgium/Chicago IL, USA: 8 May 2020 – icometrix, the world leader in software solutions for extracting clinically meaningful data from brain scans using artificial intelligence (AI), is proud to announce that Jennifer Young has join... |
| 29.04.2020 | iSTAR Medical announces outstanding results with MIGS implant | Two-year final results from STAR-I trial and initial data from STAR-II European trial tout MINIjectTM as a highly promising treatment. |
| 23.04.2020 | icometrix launches the first CE-marked image AI solution for chest CT in COVID-19 | Leuven, Belgium: 23 April 2020 – icometrix, VUB, UZ Brussel, KU Leuven, UZ Leuven, and UZ Antwerpen, together with hospitals and organizations worldwide, joined forces in a global initiative to leverage artificial intelligence (AI) in the f... |
| 17.04.2020 | Nexstim reports promising clinical outcomes of first 55 patients completing SmartFocus® rTMS treatment of Major Depressive Disorder | Helsinki, Finland: 17 April 2020 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) reports the clinical outcomes of the first 55 patients who have completed SmartFocus® rTMS therapy for treatment of major depressive disorder (MDD) at clinical sites in t... |
| 23.03.2020 | ViroVet to support COVID19 research and sample testing | Leuven, Belgium: 23 March 2019 – Belgian biotechnology company ViroVet announced today that it has made its expertise, research staff as well as part of its research facility available to support COVID19 research and sample testing in Belgi... |
| 20.03.2020 | icometrix early launching icompanion.ms | Leuven, Belgium: 20 March 2020 – Wim Van Hecke, CEO of icometrix, announces: “In the light of the COVID-19 outbreak, our team is dedicated to supporting people with Multiple Sclerosis as well as we can! There is a huge need for remote monit... |
| 17.03.2020 | Capricorn Partners invests in plant-based protein company Prolupin | Leuven, Belgium: 17 March 2020 – Capricorn Partners participates in a double-digit million growth financing round for Prolupin GmbH with an investment of € 7 million from its Capricorn Sustainable Chemistry Fund and Quest for Growth. |
| 28.02.2020 | Nexstim Plc financial statements release 2019 | Helsinki, Finland: 28 February 2020 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), today provides its financial statements for the full year 2019 (1 January–31 December 2019) and H2 2019 (1 July-31 December 2019). |
| 27.02.2020 | Confo Therapeutics to present at Cowen 40th Annual Health Care Conference | Ghent, Belgium: 27 February 2020 – Confo Therapeutics, a pioneering biopharma company, today announces that Cedric Ververken, CEO, will present at the Cowen 40th Annual Health Care Conference on Tuesday, March 3, 2020 at 3:00 p.m. ET in Bos... |
| 17.01.2020 | PREDICT-LAA trial enrolls first patient | Ghent, Belgium: 17 January 2020 – FEops, a leader in personalized predictive planning for structural heart interventions, is proud to announce that today the first patient has been enrolled in the physician-initiated PREDICT-LAA trial. The ... |
| 10.01.2020 | Sequana Medical announces first-in-human data of Direct Sodium Removal (DSR) therapy published in Circulation | Positive pre-clinical and clinical proof-of-concept data of Sequana Medical’s innovative DSR therapy published in top tier peer-reviewed cardiovascular journal Data demonstrates potential for treatment of volume overload due to heart failur... |
| 07.01.2020 | Sequana Medical announces first patient enrolled in RED DESERT – REpeated Dose alfapump® DSR study for Treatment of diuretic-resistant heart failure patients | The study aims to: |
| 10.12.2019 | FEops Awarded Euro 3.2 Million Grant From EU | Ghent, Belgium: 10 December 2019 – FEops, a leader in personalized predictive planning for structural heart interventions, has been awarded a grant of Euro 3.2 million from the European Innovation Council (EIC) accelerator programme. |
| 06.12.2019 | Mainstay Medical announces regulatory approval from Australian Therapeutic Goods Administration (TGA) for ReActiv8 | Dublin, Ireland: 6 December 2019 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and Euronext Growth operated by Euronext Dublin: MSTY.IE), today announced that it has received regulatory approval from the Australian Therapeut... |
| 05.12.2019 | Nexstim Plc: Health Canada grants Nexstim NBT® Medical Device License for Canada | Helsinki, Finland: 5 December 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that its NBT® System with SmartFocus® TMS technology has received a medical device license from Health Canada. |
| 02.12.2019 | Confo Therapeutics reports grant of two key patents for ConfoBodies™ | Ghent, Belgium: 2 December 2019 – Confo Therapeutics, a pioneering biopharma company, today announces that it has been granted two key ConfoBodyTM patents derived from the patent estate known as the “Steyaert patents”. |
| 18.11.2019 | Nexstim Plc: Shares subscribed for in the directed share issue have been registered | Helsinki, Finland: 18 November 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announced on 15 November 2019 that an aggregate of 15,687,350 new shares of Nexstim were subscribed for in the directed share issue. Such new shares have today been re... |
| 11.11.2019 | Dr Leena Niemistö starts as new Chair of the Board of Nexstim Plc | Helsinki, Finland: 11 November 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that the Extraordinary General Meeting of Shareholders has elected Leena Niemistö as the new Chair of the Board of Directors. |
| 14.10.2019 | Nexstim has placed an NBT® System with SmartFocus® technology to Stanford University Medical Center | Helsinki, Finland: 14 October 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) – the company developing and marketing a unique brain stimulation technology for personalized treatment of major depressive disorder (MDD) – announces that it has place... |
| 09.10.2019 | BlueBee establishes data center in mainland China, expanding global coverage for its Genomics Data Platform | Rijswijk, The Netherlands: 9 October 2019 – BlueBee, a global bioinformatics solutions provider, has extended data operations to mainland China to serve genomic data processing needs in compliance with The Chinese Ministry of Health and Tec... |
| 01.10.2019 | Mainstay Medical announces acceptance for filing by US FDA of Pre-Market Approval (PMA) Application for ReActiv8 | Dublin, Ireland: 1 October 2019 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and Euronext Growth of Euronext Dublin: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable neurostimulatio... |
| 27.09.2019 | Nexstim New System Sales Update | Helsinki, Finland: 27 September 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”)—the company developing and marketing a unique brain stimulation technology for diagnostics and therapy—announces it has sold one NBS System a... |
| 25.09.2019 | Sequana Medical announces first patient enrolled in North American alfapump® pivotal study (POSEIDON) | • Study aims to support the approval of the alfapump in U.S. and Canada
• Results anticipated by mid-2021
• U.S. launch of the alfapump planned for H1 2022 |
| 23.09.2019 | FierceBiotech names Confo Therapeutics as one of its “Fierce 15” Biotech Companies of 2019 | Ghent, Belgium: 23 September 2019 – Confo Therapeutics, a pioneering biopharma company, today announces that it has been named by FierceBiotech as one of 2019’s Fierce 15 biotechnology companies, designating it as one of the most promising ... |
| 19.09.2019 | Sequana Medical appoints leading experts as Heart Failure Scientific Advisors | Dr Butler, Dr Costanzo, Dr Tang and Dr Testani to advise on alfapump® DSR development |
| 19.09.2019 | Menarini Silicon Biosystems launches the MSBiosuite Bioinformatic platform, partners with BlueBee cloud-based solution automates NGS data analysis for liquid biopsy and FFPE workflows | Bologna, Italy: 19 September 2019 – Menarini Silicon Biosystems today announces the launch of the MSBiosuite, a cloud-based data analysis solution that completes the company workflow* for liquid biopsy and formalin-fixed paraffin embedded (... |
| 05.09.2019 | iSTAR Medical announces € 40 million Series C financing | To accelerate development and commercialisation of innovative Glaucoma MIGS device, MINIjectTM |
| 30.08.2019 | Capricorn Venture Partners renamed to Capricorn Partners | Leuven, Belgium: 30 August 2019 – As of today, Capricorn Partners is the new name of Capricorn Venture Partners. Capricorn Partners reflects better some recent changes in the structure of the company and the broader scope of funds that the ... |
| 30.08.2019 | LindaCare partners with Philips | LindaCare’s OnePulse combines with Philips’ IntelliSpace Cardiovascular informatics platform to streamline inhospital and remote follow-up care for patients with cardiac implantable electronic devices |
| 05.08.2019 | Nexstim NBT® system authorized for commercial distribution in Australia | Helsinki, Finland: 5 August 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) – the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of major depre... |
| 30.07.2019 | Mainstay Medical announces completion of financing transactions | • Funds to be used to support PMA process for ReActiv8® in US and to further European commercial validation efforts |
| 10.07.2019 | iSTAR Medical’s MINIject shows consistent results at 18-month follow-up in first-in-human trial (STAR-I) | Wavre, Belgium: 10 July 2019 – iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced consistent 18-month results of the first-in-human, micro-invasive glaucoma... |
| 09.07.2019 | DMC Biotechnologies announces first close of US$10.3M Series A financing led by Sofinnova Partners | Boulder, CO, USA: 9 July 2019 – DMC, an early-stage biotechnology company, announced today that is has raised a Series A equity financing led by Sofinnova Partners. The company also announced the addition to its Board of Directors of Josko ... |
